Health Check: Mesoblast shares sink despite $260m placement …

1 day ago · Dual Nasdaq-listed Mesoblast (ASX:MSB) shares have fallen ~7% today after announcing completion of a global private placement primarily to its existing major US, UK, …

7%
OFF

Health Check: Mesoblast Shares Sink Despite $260m Placement …

2 weeks from now

1 day ago · Dual Nasdaq-listed Mesoblast (ASX:MSB) shares have fallen ~7% today after announcing completion of a global private placement primarily to its existing major US, UK, …

stockhead.com.au

15%
OFF

Why Shares Of Mesoblast Are Down Monday | Nasdaq

2 weeks from now

Aug 7, 2023 · What happened. Shares of Mesoblast (NASDAQ: MESO) were down by more than 15% as of 11:45 a.m. ET on Monday, just days after the healthcare stock plunged more than …

nasdaq.com

2%
OFF

Mesoblast (NASDAQ:MESO) Trading Down 2.2% - Here's Why

2 weeks from now

19 hours ago · Mesoblast Limited (NASDAQ:MESO - Get Free Report)'s stock price traded down 2.2% on Wednesday . The company traded as low as $16.53 and last traded at $16.61. …

marketbeat.com

9%
OFF

Why Is The Mesoblast Share Price Crashing 9% Today? - The Motley …

2 weeks from now

1 day ago · The Mesoblast Ltd share price has returned from its trading halt and dropped into the red. At the time of writing, the biotech company's shares are down 9% to $2.55. Why is the …

fool.com.au

4%
OFF

MESO News Today | Why Did Mesoblast Stock Go Down Today?

2 weeks from now

5 days ago · Jane Street Group LLC raised its stake in shares of Mesoblast Limited (NASDAQ:MESO - Free Report) by 46.4% in the third quarter, according to the company in its …

marketbeat.com

$10.81
OFF

Mesoblast (NASDAQ:MESO) Shares Gap Down – Here’s Why

2 weeks from now

Oct 9, 2024 · Shares of Mesoblast Limited (NASDAQ:MESO – Get Free Report) gapped down before the market opened on Monday . The stock had previously closed at $10.81, but opened …

tickerreport.com

45%
OFF

Mesoblast Limited (MESO) Loses -5.45% In 4 Weeks, Here's Why A …

2 weeks from now

Jan 5, 2024 · Mesoblast Limited (MESO) has been beaten down lately with too much selling pressure. While the stock has lost 5.5% over the past four weeks, there is light at the end of …

nasdaq.com

7%
OFF

Why Brainchip, Fortescue, Mesoblast, And St George Mining …

2 weeks from now

Jan 7, 2025 · The Mesoblast share price is down 7% to $2.84. This may have been driven by profit taking from some investors after the biotechnology company's shares rocketed in 2024. …

fool.com.au

44%
OFF

Why Shares Of Mesoblast Are Down Monday - Barchart.com

2 weeks from now

The company's shares continued to tumble after it received a Complete Response Letter last week from the FDA. ... Mesoblast Ltd: MESO: 1.2600 +0.0300 +2.44%: Mesoblast Ltd ADR: ...

barchart.com

$10.81
OFF

Mesoblast (NASDAQ:MESO) Shares Gap Down - Here's Why

2 weeks from now

Oct 7, 2024 · Mesoblast Limited (NASDAQ:MESO - Get Free Report) gapped down prior to trading on Monday . The stock had previously closed at $10.81, but opened at $10.50. …

marketbeat.com

15%
OFF

Why Shares Of Mesoblast Are Down Monday - Sharewise

2 weeks from now

Aug 7, 2023 · Shares of Mesoblast (NASDAQ: MESO) were down by more than 15% as of 11:45 a.m. ET on Monday, just days after the healthcare stock plunged more than 61% on bad news …

sharewise.com

7%
OFF

Mesoblast (NASDAQ:MESO) Stock Price Down 5.7% – Here’s Why

2 weeks from now

Dec 29, 2024 · Shares of Mesoblast Limited (NASDAQ:MESO – Get Free Report) fell 5.7% on Friday . The stock traded as low as $17.16 and last traded at $17.25. 88,059 shares were …

etfdailynews.com

61%
OFF

Why Shares Of Mesoblast Are Plunging Friday - Nasdaq

2 weeks from now

Aug 4, 2023 · Shares of Mesoblast (NASDAQ: MESO) were down more than 61% as of 2:15 p.m. on Friday. The pharmaceutical stock is down more than 54% so far this year. So what.

nasdaq.com

$14.63
OFF

Mesoblast (NASDAQ:MESO) Shares Gap Up – Here’s Why

2 weeks from now

Dec 25, 2024 · Mesoblast Limited (NASDAQ:MESO – Get Free Report) gapped up before the market opened on Monday . The stock had previously closed at $14.63, but opened at $15.72. …

etfdailynews.com

4%
OFF

Mesoblast (NASDAQ:MESO) Shares Down 3.4% - MarketBeat

2 weeks from now

Jan 7, 2025 · Mesoblast Limited (NASDAQ:MESO - Get Free Report)'s stock price fell 3.4% during trading on Tuesday . The stock traded as low as $18.10 and last traded at $18.32. …

marketbeat.com

$20.61
OFF

Mesoblast (NASDAQ:MESO) Shares Gap Down - Here's What …

2 weeks from now

Jan 3, 2025 · Mesoblast Limited (NASDAQ:MESO - Get Free Report)'s share price gapped down prior to trading on Friday . The stock had previously closed at $20.61, but opened at $20.10. …

marketbeat.com

7%
OFF

Mesoblast (NASDAQ:MESO) Stock Price Down 5.7% - MarketBeat

2 weeks from now

Dec 27, 2024 · Mesoblast Limited (NASDAQ:MESO - Get Free Report)'s stock price traded down 5.7% during mid-day trading on Friday . The company traded as low as $17.16 and last traded …

marketbeat.com

FAQs about Health Check: Mesoblast shares sink despite $260m placement … Coupon?

Why did Mesoblast stock drop?

The FDA has rejected Mesoblast's cell therapy candidate for pediatric acute graft versus host disease, causing the stock to decline. Mesoblast is an old company located in Australia, which may impact its resonance with the FDA. The FDA has a bias against cell and other human biologic therapies, making approval for Mesoblast's therapy challenging. ...

How do I get the latest news & ratings for meso?

Sign up to receive the latest news and ratings for MESO and its competitors with MarketBeat's FREE daily newsletter. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. ...

Why did Mesoblast need a standardized potency assay?

The basis for this was a requirement the Mesoblast demonstrate that the product used in the Phase 3 trial, which was completed several years ago is similar, closely similar to the product that's intended now for commercial release, as measured by a standardized potency assay. ...

What is a Mesoblast study?

To obtain the data required, Mesoblast will conduct a targeted, controlled study in the highest-risk adults with the greatest mortality. This adult study is in line with our overall commercial strategy, which envisioned a sequenced progression from pediatric to adult SR-aGVHD indications. ...

Why did meso get a CRL from the FDA?

This is critical for MESO investors to remember, right at the top of their list of considerations. Now, coming to what they have been doing, Meso received a CRL from the FDA two years ago despite getting a 9-1 vote for approval on efficacy from the advisory committee. The FDA does not reject its own advisors’ suggestions lightly. ...

How much does meso cost?

The company says it will cost a fraction of a traditional trial by a CRO because it will be conducted by the Blood and Marrow Transplant Clinical Trials Network (BMT CTN), a body responsible for approximately 80% of all US transplants. MESO has a market cap of $183mn and a cash balance of $53mn. ...